megapharm ltd - palifermin 6.25 mg/vial - solution for injection - palifermin - kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in patients with haematological malignancies receiving myeloablative therapy associated with a high incidence of severe mucositis and requiring autologous haemopoietic stem cell support.
ישראל -
עברית -
Ministry of Health